[Title 21 CFR C]
[Code of Federal Regulations (annual edition) - April 1, 1999 Edition]
[Title 21 - FOOD AND DRUGS]
[Chapter I - FOOD AND DRUG ADMINISTRATION,]
[Subchapter H - MEDICAL DEVICES]
[Part 820 - QUALITY SYSTEM REGULATION]
[Subpart C - Design Controls]
[From the U.S. Government Printing Office]
21FOOD AND DRUGS81999-04-011999-04-01falseDesign ControlsCSubpart CFOOD AND DRUGSFOOD AND DRUG ADMINISTRATION,MEDICAL DEVICESQUALITY SYSTEM REGULATION
Subpart C--Design Controls
Sec. 820.30 Design controls.
(a) General. (1) Each manufacturer of any class III or class II
device, and the class I devices listed in paragraph (a)(2) of this
section, shall establish and maintain procedures to control the design
of the device in order to ensure that specified design requirements are
met.
(2) The following class I devices are subject to design controls:
(i) Devices automated with computer software; and
(ii) The devices listed in the following chart.
------------------------------------------------------------------------
Section Device
------------------------------------------------------------------------
868.6810.......................... Catheter, Tracheobronchial Suction.
878.4460.......................... Glove, Surgeon's.
880.6760.......................... Restraint, Protective.
892.5650.......................... System, Applicator, Radionuclide,
Manual.
892.5740.......................... Source, Radionuclide Teletherapy.
------------------------------------------------------------------------
(b) Design and development planning. Each manufacturer shall
establish and maintain plans that describe or reference the design and
development activities and define responsibility for implementation. The
plans shall identify and describe the interfaces with
[[Page 149]]
different groups or activities that provide, or result in, input to the
design and development process. The plans shall be reviewed, updated,
and approved as design and development evolves.
(c) Design input. Each manufacturer shall establish and maintain
procedures to ensure that the design requirements relating to a device
are appropriate and address the intended use of the device, including
the needs of the user and patient. The procedures shall include a
mechanism for addressing incomplete, ambiguous, or conflicting
requirements. The design input requirements shall be documented and
shall be reviewed and approved by a designated individual(s). The
approval, including the date and signature of the individual(s)
approving the requirements, shall be documented.
(d) Design output. Each manufacturer shall establish and maintain
procedures for defining and documenting design output in terms that
allow an adequate evaluation of conformance to design input
requirements. Design output procedures shall contain or make reference
to acceptance criteria and shall ensure that those design outputs that
are essential for the proper functioning of the device are identified.
Design output shall be documented, reviewed, and approved before
release. The approval, including the date and signature of the
individual(s) approving the output, shall be documented.
(e) Design review. Each manufacturer shall establish and maintain
procedures to ensure that formal documented reviews of the design
results are planned and conducted at appropriate stages of the device's
design development. The procedures shall ensure that participants at
each design review include representatives of all functions concerned
with the design stage being reviewed and an individual(s) who does not
have direct responsibility for the design stage being reviewed, as well
as any specialists needed. The results of a design review, including
identification of the design, the date, and the individual(s) performing
the review, shall be documented in the design history file (the DHF).
(f) Design verification. Each manufacturer shall establish and
maintain procedures for verifying the device design. Design verification
shall confirm that the design output meets the design input
requirements. The results of the design verification, including
identification of the design, method(s), the date, and the individual(s)
performing the verification, shall be documented in the DHF.
(g) Design validation. Each manufacturer shall establish and
maintain procedures for validating the device design. Design validation
shall be performed under defined operating conditions on initial
production units, lots, or batches, or their equivalents. Design
validation shall ensure that devices conform to defined user needs and
intended uses and shall include testing of production units under actual
or simulated use conditions. Design validation shall include software
validation and risk analysis, where appropriate. The results of the
design validation, including identification of the design, method(s),
the date, and the individual(s) performing the validation, shall be
documented in the DHF.
(h) Design transfer. Each manufacturer shall establish and maintain
procedures to ensure that the device design is correctly translated into
production specifications.
(i) Design changes. Each manufacturer shall establish and maintain
procedures for the identification, documentation, validation or where
appropriate verification, review, and approval of design changes before
their implementation.
(j) Design history file. Each manufacturer shall establish and
maintain a DHF for each type of device. The DHF shall contain or
reference the records necessary to demonstrate that the design was
developed in accordance with the approved design plan and the
requirements of this part.